Clinical Trials Logo

Knee Injury clinical trials

View clinical trials related to Knee Injury.

Filter by:

NCT ID: NCT00894595 Completed - Knee Injury Clinical Trials

Preventing Knee Injuries in Adolescent Female Football Players

Start date: August 2008
Phase: N/A
Study type: Interventional

Football-related knee injuries are common and especially the anterior cruciate ligament (ACL) injury constitute a serious problem in football regardless of the playing level. The purpose of this study is to conduct a randomized controlled trial evaluating the effect of a training program designed to prevent acute knee injury in female adolescent football players. The investigators' hypotheses are: 1. a preventive training program reduces the incidence of ACL injury, and 2. a high match frequency and match play at senior level increase the risk of ACL injury.

NCT ID: NCT00821873 Completed - Knee Injury Clinical Trials

Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee.

CRB
Start date: December 2008
Phase: Phase 3
Study type: Interventional

The main objective of this study is to test the ability of an allograft plug to provide a successful repair of an osteochondral defect left at the harvest site during OATS procedure.

NCT ID: NCT00793104 Terminated - Knee Injury Clinical Trials

Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee.

Start date: November 2008
Phase: Phase 3
Study type: Interventional

Determine the ability of the allograft plug for the treatment of a cartilage injury in the knee

NCT ID: NCT00696319 Suspended - Knee Injury Clinical Trials

Dynamic Stability of the Anterior Cruciate Ligament (ACL) Deficient Knee

Start date: January 2007
Phase: N/A
Study type: Interventional

The study that is registered in ClinicalTrials is a part study of an overall study with the title 'Dynamic stability of the ACL-injured knee'. The aim of the overall study is to prospectively follow a cohort of newly injured patients with total rupture of the anterior cruciate ligament in the knee, in order to document results from different rehabilitation regimes after the injury. The title of the part study is 'Neuromuscular changes in ACL-deficient individuals before and after an intensive perturbation training program. A case-control study.' The aims of the part study are: 1. To describe muscle activation patterns, joint angles and forces during gait and one-legged hop in newly injured ACL-deficient individuals before and after execution of an intensive training program consisting of either perturbation training or conventional balance- and stability training 2. To describe eventual changes between the two groups that may indicate superiority of either one of the methods The study will include 25 subjects in each group. The intervention consists of two different rehabilitation protocols for neuromuscular training. Subjects will be tested in a biomechanical laboratory before and after intervention, with use of 3D camera systems, force plates and electromyographic measurements (EMG). Main outcomes are eventual differences in muscle activation patterns, joint angles and forces during selected phases of walking and one-legged hopping. Secondary outcomes of interest are self-assessment of knee function, isokinetic strength and functional one-legged hop tests. Status: Inclusion to the main study started in January 2007. Data collection for the case-control part study will take place in 2008-2009. The part study study should be finished in 2010, where results will be included in a PhD dissertation. The PhD student responsible, Ingrid Eitzen, is enrolled in the Doctoral program at the Faculty of Medicine, University of Oslo. She is employed at Orthopaedic Centre, Ullevaal University Hospital and part of The Norwegian Research Center for Active Rehabilitation (NAR). The project is included in the NAR research program. In addition, the overall study is organized as a formalized collaboration with the University of Delaware, US, where they also will follow a cohort of 150 subjects.

NCT ID: NCT00687921 Not yet recruiting - Knee Injury Clinical Trials

F18-Flouride PET/CT in Acute Knee Injury

Start date: June 2008
Phase: N/A
Study type: Observational

18F-fluoride is a positron-emitting bone-seeking agent with favorable pharmacokinetic properties. Its uptake mechanism resembles that of 99mTc-MDP. After IV administration, 18F-fluoride diffuses through the bone capillaries into the bone extracellular fluid (ECF). Its plasma clearance is more rapid than that of 99mTc-MDP and its single-passage extraction efficiency is higher. The fast blood clearance of 18F-fluoride results in a better target- to- background ratio. Bone uptake of 18F-fluoride is two-fold higher than that of 99mTc-MDP. Combining the favorable pharmacokinetic characteristics of 18F-fluoride with the high performance of PET technology, 18F-fluoride is a valuable imaging modality of the skeleton. There are only few manuscripts on the role of static 18F-fluoride PET for detection of lesions in patients referred for non-oncologic indications The purpose of the study is to prospectively assess the added value of Fluoride PET/CT in the clinical setting of acute knee injury. The findings of Fluoride PET/CT will be correlated with those found on arthroscopy and MRI which the currently used diagnostic techniques with a high, however, not perfect diagnostic accuracy regarding the issue of bone injury which is a critical component on the long term outcome after knee injury.

NCT ID: NCT00332254 Completed - Knee Injury Clinical Trials

Study to Prevent Cartilage Damage Following Acute Knee Injury.

Start date: March 2006
Phase: Phase 1/Phase 2
Study type: Interventional

Individuals who have had a severe knee injury have an increased risk of developing arthritis of the knee and at a much earlier age than would otherwise be expected. The swelling and inflammation that occur after injury are believed to be responsible for this cartilage damage. The cartilage (material that provides a cushion in the knee) is the primary protection from what is called degenerative arthritis or osteoarthritis. We hope to reduce this swelling and prevent the damage to cartilage that occurs after injury by injecting a medication that blocks one of the proteins responsible for inflammation and cartilage breakdown. This protein is called interleukin-1 and can be inhibited by an interleukin-1 receptor antagonist called anakinra. Anakinra will be injected directly into the injured knee and response to the injection will be measured by symptoms and analysis of cartilage breakdown in the knee fluid and blood.